Get latest articles and stories on Latest News at LatestLY. Glenmark Pharmaceuticals Ltd on Thursday said its arm Glenmark Specialty S A (GSSA) has signed a license agreement with Jiangsu Alphamab Biopharmaceuticals Co and 3D Medicines (Beijing) Co Ltd for KN035 (Envafolimab), used in cancer treatment.
Latest News | Glenmark Inks Licensing Pact with Jiangsu Alphamab, 3D Medicines for Cancer Drug.
Related Keywords
New Delhi ,Delhi ,India ,China ,Bihar ,Beijing ,Russia ,United States ,Chinese ,America ,Jiangsu Alphamab ,Asia Pacific ,Bharat Ratna ,Glenn Saldanha ,Karpoori Thakur ,Tracon Pharma ,D Medicines Beijing Co Ltd ,National Medical Products Administration Chinese ,Glenmark Pharmaceuticals Ltd On ,Jiangsu Alphamab Biopharmaceuticals Co ,Drug Administration ,Glenmark Pharmaceuticals ,Glenmark Pharmaceuticals Ltd ,Middle East ,Latin America ,Who Is Karpoori ,Know All About Former Bihar ,Pharmaceuticals Chairman ,Managing Glenn Saldanha ,National Medical Products Administration ,Biliary Tract ,
comparemela.com © 2020. All Rights Reserved.